Levels of sCD40 Ligand in Chronic and Acute Coronary Syndromes and its Relation to Angiographic Extent of Coronary Arterial Narrowing

Author:

Fouad Hanan H.1,Al-Dera Husain2,Bakhoum Sameh W.3,Rashed Laila A.1,Sayed Rehab H.1,Rateb Moshira A.4,Haidara Mohamed A.5,Soskic Sanja6,Isenovic Esma R.6

Affiliation:

1. Department of Medical Biochemistry, Kasr Al-Aini Faculty of Medicine, Cairo University, Giza, Egypt

2. Department of Physiology, College of Medicine, King Saud bin Abdulaziz University for Health Science, Riyadh, Saudi Arabia

3. Department of Cardiology, Kasr Al-Aini Faculty of Medicine, Cairo University, Giza, Egypt

4. Department of Physiology, Kasr Al-Aini Faculty of Medicine, Cairo University, Giza, Egypt

5. Department of Physiology, College of Medicine, King Khalid University, Abha, Saudi Arabia,

6. Department for Molecular Genetics and Radiobiology, Vinča Institute, University of Belgrade, Belgrade, Serbia

Abstract

We determined the serum levels of soluble CD40 ligand (sCD40L) in patients with chronic coronary artery disease (CAD) and acute coronary syndrome (ACS). Patients with unstable angina (UA) and myocardial infarction (MI) showed significantly higher levels (P < .001) of sCD40L compared with patients with stable angina (SA) and controls; particularly, high levels occurred in patients with UA (UA: 9.23 ± 2.92, MI: 7.38 ± 1.05, SA: 4.42 ± 1.08; control: 4.01 ± 0.87 ng/mL). There was no significant difference in sCD40L levels between patients with UA and MI or between patients with SA and controls. Levels of sCD40L did not show any significant correlation with peak creatine kinase (CK), CK-MB isoenzyme activity in patients with MI, troponin T serum levels in patients with UA or with culprit vessel (CV) complexity score (CVCS), type of CV lesion, or vessel score in patients with UA or MI. These results suggest that CD40L plays a pathogenic role in triggering ACS.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3